U.S. VA Awards Genelex Contract to Reduce Veterans’ Healthcare Costs

The U.S. Department of Veterans Affairs has awarded a Federal Supply Schedule contract to Genelex as a government supplier, which took effect March 15th, 2016. The contract makes pharmacogenetic testing accessible to clinicians in the Veterans Administration, so their patients can immediately benefit from precision medicine. The approval will also allow healthcare providers in the Department of Defense, Bureau of Indian Affairs, the Federal Bureau of Prisons, and several other government agencies to have access to this technology to reduce healthcare costs and improve patient care.

 

The YouScript Precision Prescribing System not only reveals drug-gene interactions, but interactions between genes and multiple drugs to help providers find the best treatment for patients. Tests available to veterans include the YouScript Psychotropic Test Panel, which optimizes treatment for patients suffering from mental health conditions such as post-traumatic stress disorder, and the YouScript Polypharmacy Panel, which helps predict response to over three-quarters of commonly prescribed medications including those for pain management, mental health, and heart conditions.

 

Read more by clicking here.

One Comment on “U.S. VA Awards Genelex Contract to Reduce Veterans’ Healthcare Costs”

  1. Pingback: White House 2016 Precision Medicine Initiative Summit – Recap - PGx In Practice Blog

Leave a Reply

Your email address will not be published. Required fields are marked *